NASDAQ: IAM · Health Care / Biotechnology: Biological Products (No Diagnostic Substances)

Iambic Therapeutics Inc.

How Iambic Therapeutics Inc. compares with its industry, its sector and the market: price, value, growth, profit and risk.

Market cap
$1.1B
Price
$23.81
52-week range
$18.91–$23.81

Compared with

For information only, not investment advice. Data may contain errors. Disclaimer · Sources